Lab to Market: Collaborative Strategies for Faster Patient Access
Friday, September 8, 2023 12:30 PM - 01:30 PM
Grand Ballroom L
The panel discussion titled "From Lab to Market: Key Drivers of Collaborative Success in Commercializing Therapeutic Innovations" shed light on the critical factors that contribute to successful collaboration between the scientific community and commercial entities in bringing innovations from the laboratory to the market. The discussion was held with the aim of identifying key drivers that can accelerate the process of commercializing scientific discoveries and bridging the gap between academic research and real-world applications.
Session Objectives
Chair
Tim Maguire, PhD, Global Business Development and Operations Leader in Cell and Gene Therapy, Resilience, USA
Speakers
Session Objectives
- Learn key drivers of success for pre-clinical and clinical programs
- Highlight novel funding
Chair
Tim Maguire, PhD, Global Business Development and Operations Leader in Cell and Gene Therapy, Resilience, USA
Speakers
- Patrick Starremans PhD, Head of Gene Therapy Analytical Development, Resilience, USA
- Waye Leeuwon, PhD, Program Manager for Product Development Research, CPRIT, USA
- Andrew Dennis, PhD, Associate Vice President, Office of Technology Commercialization, MDACC, USA
- Jason Bock, PhD, CEO, CTMC
SPONSORED BY:
